Search results
Results From The WOW.Com Content Network
The main treatment for acute lymphocytic leukemia (ALL) in adults is typically long-term chemotherapy (chemo). Sometimes other types of drugs, such as targeted drugs or immunotherapy , might be part of the treatment as well.
In general, treatment for acute lymphocytic leukemia falls into separate phases: Induction therapy. The purpose of the first phase of treatment is to kill most of the leukemia cells in the blood and bone marrow and to restore normal blood cell production. Consolidation therapy.
Acute lymphoblastic leukemia (ALL) treatment options include chemotherapy, radiation therapy, stem cell transplant, and/or targeted therapy. Get detailed information about newly diagnosed and recurrent ALL in this expert-reviewed summary.
Acute lymphoblastic leukemia (ALL) is a rare blood cancer. Anyone can develop ALL, but it’s more common in young children than in teenagers and adults. Thanks to newer treatments, people are living longer with ALL.
Acute lymphoblastic leukemia (ALL) treatment options include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Get detailed information about the molecular genetics, prognosis, and treatment of ALL in this summary for clinicians.
Common treatment approaches. Treatment of ALL typically lasts for about 2 years. It is often intense, especially in the first few months of treatment, so it's important that you are treated in a center that has experience with this disease. The treatment approach for children with ALL can be slightly different from that used for adults.
Continuing Education. Adult Acute Lymphocytic Leukemia: Strategies for Selection of Consolidation Therapy. Case Studies in the Management of Leukemia. Recorded Presentation from the NCCN Pharmacy Updates: Updates in the Treatment of Adult Acute Lymphoblastic Leukemia.
Chemotherapy is the major form of treatment for leukemia. This drug treatment uses chemicals to kill leukemia cells. Depending on the type of leukemia you have, you may receive a single drug or a combination of drugs. These drugs may come in a pill form, or they may be injected directly into a vein. Targeted therapy.
The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and ...
Overview. Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. The word "acute" in acute lymphocytic leukemia comes from the fact that the disease progresses rapidly and creates immature blood cells, rather than mature ones.